Page results
-
UCLH patient information for using Control IQ technology
-
UCLH Learning Disabilities and Autism Team Telephone: 020 3447 8238 Email: uclh.referrals.learning.disabilities@nhs.net…
-
This page will give you an overview of intravesical thermo-chemotherapy, how it is given and side effects it may cause.
-
This page will give you an overview of intravesical chemotherapy, how it is given and side effects it may cause.
-
This page will give you an overview of intravesical RF induced thermochemotherapy, how it is given and side effects it may cause.
-
The following information has been written by the Specialist Physiotherapist who works for the Mitochondrial service. The page provides information about activity and exercise for people living with…
-
Benefits of exercise Improve aerobic conditioning (physical activity endurance). Improve efficiency in getting into the second wind. Prevent muscle weakness due to inactivity. Control…
-
This page will give you an overview of intravesical chemotherapy, how it is given and side effects it may cause.
-
This booklet has been written by tracheostomy team at The National Hospital for Neurology and Neurosurgery. It is intended to provide information for patients (or their families and carers) about…
File results
-
FOI/2024/0445 - Framework agency spend for locum doctors for February to March 2024
-
FOI/2024/0535 - Agency spend, providers and department contacts for locums by specialities and sites
-
FOI/2024/0537 - SHO doctor shifts covered by physician associates December 2023-May 2024
-
FOI/2024/0554 - Robotic Process Automation (RPA) Programme
-
FOI/2024/0550 - Syntometrine vs Misoprostol/ treatment uses for post-partum haemorrhage
-
FOI/2024/0559 - Surgical Robots purchase/ simulators/ procedures 2019-2024
-
FOI/2024/0580 - Newborns taken into care from the maternity wards 2019-2023
-
FOI/2024/0581 - Weight management services/ bariatric surgery/ access to Wegovy
-
FOI/2024/0588 - Spend with framework agencies for locum nurses - January to June 2024
-
FOI/2024/0589 - SACT Cancer report/ Drug Patient Level Contract Monitoring (DrPLCM) report